<DOC>
	<DOCNO>NCT00621218</DOCNO>
	<brief_summary>To compare efficacy safety tretinoin gel 0.05 % vehicle dose twice daily female subject rosacea .</brief_summary>
	<brief_title>A Study Determine Safety Efficacy Atralin ( Tretinoin 0.05 % ) Gel Treatment Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>Female Age 1865 Diagnosed classical , centrofacial , erythematotelangiectatic rosacea Male , females less 18 year Females 65 year No diagnosed rosacea</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>tretinoin , efficacy , safety , rosacea</keyword>
</DOC>